Aptevo Therapeutics (APVO) Return on Sales (2015 - 2022)
Aptevo Therapeutics (APVO) posted Return on Sales of 0.0% for Q4 2022, up 169.92% sequentially from 0.0% in Q3 2022, and little changed YoY from 0.0% in Q4 2021.
Aptevo Therapeutics (APVO) Return on Sales (2015 - 2022) Analysis & Trends
Aptevo Therapeutics has reported Return on Sales for 8 years, with the latest figure at 0.0% in Q4 2022.
- Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q4 2022, while the trailing twelve-month figure through Dec 2022 was 0.0% (changed 0.0% YoY) and the FY2022 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Sales improved to 0.0% in Q4 2022 per APVO's latest filing, from 0.0% in the prior quarter.
- Over five years, Return on Sales peaked at 0.01% in Q2 2020 and troughed at 0.06% in Q4 2020.
- A 5-year average of 0.0% and a median of 0.0% in 2022 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2018 and 2021: Return on Sales dropped 9 bps in 2018, then increased 6 bps in 2021.
- Over 5 years, Return on Sales stood at 0.0% in 2018, then soared by 1921 bps to 0.0% in 2019, then slumped by 5008 bps to 0.06% in 2020, then surged by 101 bps to 0.0% in 2021, then soared by 267 bps to 0.0% in 2022.
- According to Business Quant data, Return on Sales over the past three periods registered 0.0%, 0.0%, and 0.0% for Q4 2022, Q3 2022, and Q2 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Aptevo Therapeutics | 3.33 Mn | -6.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | -0.06% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 0.01% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | 0.00% |
| Mar 31, 2019 | 0.00% |
| Sep 30, 2018 | 0.00% |
| Jun 30, 2018 | 0.00% |
| Mar 31, 2018 | 0.00% |
| Sep 30, 2017 | 0.09% |
| Jun 30, 2017 | 0.01% |